Prescription drug list (formulary) - Coverage Criteria
Customize your policy alerts
Sign up for all SelectHealth policy alerts
Know when SelectHealth releases new policies or updates existing guidance.
Monitor payer policy activity
This document is a summary of commonly prescribed drugs covered by SelectHealth plans (the formulary), including tier placement, special requirements (e.g., preauthorization, step therapy, quantity limits, age limits), and guidance for members and providers on coverage and costs.
No material clinical or coverage changes in this revision.
Coverage Criteria Overview
This formulary extract lists covered prescription drugs and also identifies medications that are not covered by the plan. For drugs that are not covered, a coverage exception may be requested by the member, the prescribing physician, or the dispensing pharmacy. Requests for coverage of noncovered drugs are considered on a case‑by‑case basis and must demonstrate medical necessity. To initiate a request, submit the Drug Coverage Exception Form available on the plan website.
Provider Actions, Authorization, and Documentation
Preauthorization Required
Coverage of drugs is based on medical necessity. For certain drugs, preauthorization (PA) is required before the plan will cover the medication. If you do not obtain required preauthorization, the member may be financially responsible for the drug's full retail price.
- Preauthorization required for select products — PA flags are shown in the product lists (e.g., many specialty, oncology, pulmonary arterial hypertension, and higher‑tier agents).
- Absence of a required PA may result in claim denial or member financial responsibility.
Prior Authorization for Listed and Higher‑Tier Drugs
Some listed drugs and higher‑tier products (notably Tier 5–6 and many specialty/oncology agents) carry a Prior Authorization requirement. Examples from the formulary include multiple oncology agents, PAH agents (e.g., Ambrisentan, Alyq), and certain Tier 5–6 injectables and oral specialty products.
- Look for (PA) next to drug entries in the product lists — these products require prior authorization before coverage is approved.
- Many Tier 5–6 products and specialty injectables have PA + QL + M flags; review the specific drug row for all requirement flags.
Step Therapy Requirement and Risk
Step therapy (ST) requires trying an alternative therapy first; coverage may be denied if step requirements are not met. Step therapy most often applies to brand‑name and certain specialty products.
- Products tagged (ST) in the formulary must meet step‑through criteria prior to coverage.
- Failure to satisfy step therapy requirements can cause claim denial or additional processing delays.
Requirement Flags and Denial Risk
Quantity limits (QL), age limits (AGE), medical justification (M), step therapy (ST), and prior authorization (PA) flags indicate additional requirements. If the corresponding requirement is not met or documented, claims may be denied or require additional review.
- (QL): Quantity limits — exceeding limits may require PA or documentation and can result in denial.
- (AGE): Age limits — verify member age for product eligibility.
- (M): Medical documentation may be required to support medical necessity.
- (ST)/(PA): Step therapy or prior authorization flags present on product rows are potential denial triggers if not satisfied.
Documentation Expectations for Flagged Products
Documentation must support any flagged requirement (PA, QL, ST, M, AGE). Provide clinical rationale, prior treatment history, relevant labs or imaging, and member age when applicable to expedite reviews.
- For PA requests include diagnosis, prior therapies and dates, reason for failure or intolerance, and expected duration of therapy.
- For QL or ST exceptions, include dosing history and justification for exceedance or bypassing step therapy.
- Use the Drug Coverage Exception Form (available on our website) to request coverage for noncovered drugs or to request exceptions.
- Incomplete documentation may delay review or lead to denial.
Coverage Exception Requests
Coverage exception requests (Drug Coverage Exception) may be submitted when a drug is not covered or when a member needs an exception to PA/QL/ST requirements. These are reviewed on a case‑by‑case basis.
- Submit the Drug Coverage Exception Form found on the payer website.
- Include supporting clinical documentation and the specific reason for the exception (e.g., prior therapy failure, contraindication, age exception).
- If an exception is granted it will be documented and applied to the member’s coverage; if denied, standard PA and cost‑sharing rules apply.
Formulary Flags and Definitions
Step Therapy Requirements and Affected Products
| Drug / Product | Tier | Requirement(s) |
|---|---|---|
| Adapalene Gel | 3 | (ST) |
| Clindamy/Ben Gel | 4 | (ST) |
| Dapsone | 4 | (ST) |
| Icosapent Capsule | 4 | (ST)(QL)(M) |
| Pitavastatin Tablet | 3 | (ST)(QL)(M) |
| Repatha Injectable | 4 | (PA)(QL)(M); Repatha Injectable entry also shows (ST)(QL) |
| Travoprost Dro (ophthalmic) | 4 | (ST)(QL)(M) |
| Imvexxy Main Sup / Strt Sup (topical) | 5 | (ST)(QL)(M) |
| Various ophthalmic prostaglandins (e.g., Bimatoprost, Latanoprost, Lumigan) | 2-4 | Some entries include (ST) or (QL)(M) as shown per product |
| Additional Product Example | Tier | Requirement(s) |
|---|---|---|
| Icosapent Capsule | 4 | (ST)(QL)(M) |
| Omega-3-Acid Capsule | 3 | (QL)(M) |
| Pitavastatin Tablet | 3 | (ST)(QL)(M) |
| Travoprost Dro | 4 | (ST)(QL)(M) |
| Imvexxy Main Sup / Imvexxy Strt Sup | 5 | (ST)(QL)(M) / (ST)(M) |
| Supplemental Product | Tier | Requirement(s) |
|---|---|---|
| Adapalene Gel | 3 | (ST) |
| Diltiazem (Dilt-Xr Capsule / Diltiazem) | 2-3 | (ST)(QL)(M) |
| Ivermectin | 4 | (ST)(QL) |
| Repatha Injectable (listed also with ST on another line) | 4 | (PA)(QL)(M) and elsewhere (ST)(QL) |
| Travoprost Dro | 4 | (ST)(QL)(M) |
| Agent / Product | Tier | Requirement(s) |
|---|---|---|
| Adapalene Gel | 3 | (ST) |
| Clindamy/Ben Gel | 4 | (ST) |
| Dapsone | 4 | (ST) (one line also shows (AGE) on alternate entry) |
| Pitavastatin Tablet | 3 | (ST)(QL)(M) |
| Icosapent Capsule | 4 | (ST)(QL)(M) |
| Repatha Injectable | 4 | (PA)(QL)(M) and listed with (ST)(QL) on another entry |
| Imvexxy Main Sup / Imvexxy Strt Sup | 5 | (ST)(QL)(M) / (ST)(M) |
| Travoprost Dro | 4 | (ST)(QL)(M) |
| Various oncology and specialty agents (examples shown in section) - see entries | various | Some oncology entries in the section are flagged with (ST) where shown |
Quantity Limits and Affected Drugs
Background and Formulary Structure
The formulary groups medications by therapeutic category and assigns them to cost tiers. Entries may show special administrative requirements and limits using shorthand flags: PA = preauthorization required, ST = step therapy (trial of a preferred alternative required), QL = quantity limits, M = maintenance drug (90‑day supply option), and AGE = age‑based restrictions. The list is maintained and reviewed regularly by the clinical team; where flags appear on a drug line, applicable documentation or prior approval must be obtained to secure coverage.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.